Ongoing experiments, research funding, and scientists' careers are all at stake.
From now until Jan. 29, save 40% off of an annual STAT+ subscription and get unlimited access to our award-winning journalism, premium data tools, event discounts, and more. Sign up here. |
|
|
 Win McNamee/Getty Images
Trump's restrictions spark chaos across health and science agencies While some restrictions during a presidential transition are routine, the administration's moves go far beyond that, interrupting the basic functions of health agencies and threatening to derail ongoing experiments, hamstring research funding, and damage the careers of young scientists. Read more. By Lev Facher, Jason Mast, and Angus Chen |
|
-jpg.jpeg?width=1252&height=704&upscale=true&name=GettyImages-153658051-2048x1152%20(1)-jpg.jpeg) FRED DUFOUR/AFP via Getty Images
Inside the looming crisis in the infant formula market Hundreds of parents have sued both Abbott and Mead Johnson's parent company, Reckitt Benckiser, the two major makers of preterm infant formula, over allegedly failing to warn that their products could increase the risk of necrotizing enterocolitis. But the lawsuits, three neonatologists told STAT, are based on shaky scientific ground. Even worse, Abbott has said if the company continues to lose cases, it may exit the preterm infant formula market completely. Read more. By Lizzy Lawrence
 Adobe
Cancer therapy's new 'gold rush': bispecific antibodies that hit key combination of targets Immune checkpoint inhibitors, drugs that can help make the immune system recognize and destroy cancer more aggressively, are one of the most important medicines in cancer treatment today. Now, a new class of drugs may be emerging to challenge the dominance of these first-generation checkpoint inhibitors. Read more. By Angus Chen
In case you missed it |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2025, All Rights Reserved. | |
|
No comments